SCHEMBL11071409

SCHEMBL11071409

N#Cc1cc2c([nH]c1=O)oc1cnccc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 3/20 0.43
PDE3A Q14432 3/20 0.43
KDM4E B2RXH2 1/20 0.43
PDE5A O76074 1/20 0.43
LMNA P02545 1/20 0.43
HPGD P15428 1/20 0.43
TSHR P16473 1/20 0.43
PTGS1 P23219 1/20 0.43
PDE4A P27815 1/20 0.43
CYP2C19 P33261 1/20 0.43
BLM P54132 1/20 0.43
PDE4B Q07343 1/20 0.43
PDE4C Q08493 1/20 0.43
PDE4D Q08499 1/20 0.43
KDM5A P29375 1/20 0.40
KDM5C P41229 1/20 0.40
KDM5B Q9UGL1 1/20 0.40
PIK3CD O00329 1/20 0.40
PIK3CA P42336 1/20 0.40
PIK3CB P42338 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11071637 0.89 PDE3B (0.43) PDE3BPDE3AKDM4EPDE5ALMNA
SCHEMBL11069631 0.80 KDM4E (0.48) KDM4ELMNAHPGDHTT
SCHEMBL11075196 0.73 KDM4E (0.39) PDE3BPDE3AKDM4EPDE5ALMNA
SCHEMBL11064177 0.73 KDM5A (0.46) KDM4EHPGDPDE4APDE4BPDE4C
SCHEMBL7340847 0.71 DYRK1A (0.49) PDE3BPDE3AKDM4EPDE5ALMNA
SCHEMBL11078482 0.70 PDE3B (0.43) PDE3BPDE3AKDM4EPDE5ALMNA
SCHEMBL28872678 0.68 DAO (0.59) PDE3BPDE3AKDM4EPDE5ALMNA
SCHEMBL10816475 0.68 DAO (0.59) PDE3BPDE3AKDM4EPDE5ALMNA
SCHEMBL11075488 0.68 PDE3B (0.43) PDE3BPDE3AKDM4EPDE5ALMNA
SCHEMBL6588265 0.66 PARP1 (0.46) PDE3BPDE3AKDM5AKDM5CKDM5B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4474786-A CONGESTIVE HEART FAILURE SCHERING CORPORATION (US) 1984-10-02 US disclosed
EP-0102046-A1 Tricyclic lactams, method for making them, pharmaceutical compositions containing them SCHERING CORPORATION (US) 1984-03-07 EP disclosed